Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Abstract Text:

    sophie parkSophie Park,sophie grabarSophie Grabar,charikleia kelaidiCharikleia Kelaidi,odile beyne-rauzyOdile Beyne-Rauzy, picard Picard, bardet Bardet, coiteux Coiteux, leroux Leroux,pascale lepelleyPascale Lepelley, daniel Daniel, cheze Cheze, ,augustin ferrantAugustin Ferrant,christophe ravoetChristophe Ravoet,martine escoffre-barbeMartine Escoffre-Barbe,lionel Lionel ,norbert veyNorbert Vey,lina aljassemLina Aljassem,aspasia stamatoullasAspasia Stamatoullas,lionel mannoneLionel Mannone, dombret Dombret,keith bourgeoisKeith Bourgeois,peter greenbergPeter Greenberg,pierre fenauxPierre Fenaux, dreyfus Dreyfus, ,sophie parkSophie Park,sophie grabarSophie Grabar,charikleia kelaidiCharikleia Kelaidi,odile beyne-rauzyOdile Beyne-Rauzy,françoise picardFrançoise Picard,valérie bardetValérie Bardet,valérie coiteuxValérie Coiteux,geneviève lerouxGeneviève Leroux,pascale lepelleyPascale Lepelley,marie-thérèse danielMarie-Thérèse Daniel,stéphane chezeStéphane Cheze,béatrice mahéBéatrice Mahé,augustin ferrantAugustin Ferrant,christophe ravoetChristophe Ravoet,martine escoffre-barbeMartine Escoffre-Barbe,lionel adèsLionel Adès,norbert veyNorbert Vey,lina aljassemLina Aljassem,aspasia stamatoullasAspasia Stamatoullas,lionel mannoneLionel Mannone,hervé dombretHervé Dombret,keith bourgeoisKeith Bourgeois,peter greenbergPeter Greenberg,pierre fenauxPierre Fenaux,françois dreyfusFrançois Dreyfus, ,

    We analyzed prognostic factors of response, response duration, and possible impact on survival of epoetin alpha, epoetin beta, or darbepoetin alpha (DAR) with or without granulocyte colony-stimulating factor in 403 myelodysplastic syndrome (MDS) patients. Sixty-two percent (40% major and 22% minor) and 50% erythroid responses were seen, and median response duration was 20 and 24 months according to IWG 2000 and 2006 criteria, respectively. Significantly higher response rates were observed with less than 10% blasts, low and int-1 International Prognostic Scoring System (IPSS), red blood cell transfusion independence, serum EPO level less than 200 IU/L, and, with IWG 2006 criteria only, shorter interval between diagnosis and treatment. Significantly longer response duration was associated with major response (IWG 2000 criteria), IPSS low to INT-1, blasts less than 5%, and absence of multilineage dysplasia. Minor responses according to IWG 2000 were reclassified as "nonresponders" or "responders" according to IWG 2006 criteria. However, among those IWG 2000 minor responders, response duration did not differ between IWG 2006 responders and nonresponders. Multivariate adjusted comparisons of survival between our cohort and the untreated MDS cohort used to design IPSS showed similar rate of progression to acute myeloid leukemia in both cohorts, but significantly better overall survival in our cohort, suggesting that epoetin or DAR treatment may have a favorable survival impact in MDS.

    Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Publishing Authors By Initials

    s parkS Park,s grabarS Grabar,c kelaidiC Kelaidi,o beyne-rauzyO Beyne-Rauzy,f picardF Picard,v bardetV Bardet,v coiteuxV Coiteux,g lerouxG Leroux,p lepelleyP Lepelley,mt danielMT Daniel,s chezeS Cheze,b B ,a ferrantA Ferrant,c ravoetC Ravoet,m escoffre-barbeM Escoffre-Barbe,l L ,n veyN Vey,l aljassemL Aljassem,a stamatoullasA Stamatoullas,l mannoneL Mannone,h dombretH Dombret,k bourgeoisK Bourgeois,p greenbergP Greenberg,p fenauxP Fenaux,f dreyfusF Dreyfus, ,s parkS Park,s grabarS Grabar,c kelaidiC Kelaidi,o beyne-rauzyO Beyne-Rauzy,f picardF Picard,v bardetV Bardet,v coiteuxV Coiteux,g lerouxG Leroux,p lepelleyP Lepelley,mt danielMT Daniel,s chezeS Cheze,b mahéB Mahé,a ferrantA Ferrant,c ravoetC Ravoet,m escoffre-barbeM Escoffre-Barbe,l adèsL Adès,n veyN Vey,l aljassemL Aljassem,a stamatoullasA Stamatoullas,l mannoneL Mannone,h dombretH Dombret,k bourgeoisK Bourgeois,p greenbergP Greenberg,p fenauxP Fenaux,f dreyfusF Dreyfus, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Blood

    VOLUME: 111

    Page Numbers: 574-82

    Journal Abbreviation: Blood

    ISSN: 0006-4971

    DAY: 16

    MONTH: 10

    YEAR: 2007

    Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7603509

    Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.

    AFFILIATION:

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Blood

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News